N Engl J Med 2016;375:32334
GLP-1 receptor agonist medicines such as Wegovy (semaglutide) or Mounjaro (tirzepatide) are designed to be taken once weekly
Therefore, investigating the potential genetic benefits of GLP-1RAs for individuals with SA is of significant interest
In a large study published in the New England Journal of Medicine, Semaglutide (which is the active ingredient in both Ozempic) led to an average weight loss of about 15% of the body weight in about a year, which is an average total weight loss of about 33.7 lbs
View the current Elevate Health GLP-1 offer (official Elevate Health page) Important: Elevate Health operates as a telehealth platform that connects users with independent, licensed medical providers
Nor Hanipah Z, Punchai S, Birriel TJ, Lansang MC, Kashyap SR, Brethauer SA, et al